№ lp_2_3_38751
File format: docx Character count: 21309 File size: 151 KB
Year: 2023
Region / City: United Kingdom
Topic: Inflammatory Bowel Disease (IBD) Research
Document Type: Patient Information Sheet
Organization / Institution: NIHR BioResource
Author: Not specified
Period of Validity: Ongoing
Approval Date: 21/07/23
Date of Amendments: Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Steroid use and misuse- a key performance indicator in the management of IBD
Year: 2021
Region / City: London, UK
Topic: Inflammatory Bowel Disease, Corticosteroids
Document Type: Article
Author: Blackwell J, Selinger CP, Raine T, Parkes GC, Smith M, Pollok RCG
Target Audience: Healthcare professionals, researchers
Date Approved: 2021
Date of Changes: Not specified
Selecting a Thesis Advisor and Committee for IBD Graduate Program
Note: Year
Supplementary Table 1: Groups of IBD surgeries and ICD8 and 10 codes
Year: 2023
Region / City: Not specified
Topic: IBD surgeries, ICD codes, pregnancy-related outcomes
Document type: Table
Organization: Not specified
Author: Not specified
Target audience: Medical professionals, researchers
Period of validity: Not specified
Date of approval: Not specified
Date of changes: Not specified
Clinical Research Databases for IBD Studies and Available Support Services
Year: 2011 - Present
Region / City: University of Pennsylvania, USA
Topic: Clinical Research, Immunology, IBD (Inflammatory Bowel Disease)
Document Type: Research Database Listing
Organization / Institution: University of Pennsylvania Health System
Author: Meenakshi Bewtra, Jim Lewis, Marina Serper
Target Audience: Researchers, Healthcare Providers, Clinicians
Period of Action: Ongoing
Approval Date: Not specified
Modification Date: Not specified
Note: Contextual Description
Supplemental Tables 1–5: Codes, Sensitivity Analysis, and SPARC IBD Cohort Characteristics for Crohn’s Disease Study
Year: 2022
Country: United States
Study name: Study of a Prospective Adult Research Cohort with IBD (SPARC IBD)
Affiliated organization: Crohn’s & Colitis Foundation
Study type: Prospective cohort study
Number of centers: 17
Population: Adult patients with Crohn’s disease initiating vedolizumab or ustekinumab after anti-TNF therapy
Exposures: Ustekinumab, Vedolizumab, Anti-TNF inhibitors
Outcomes: Treatment discontinuation, Crohn’s disease–related surgery, malignancy, cardiac events, thromboembolic events
Data sources: Commercial claims data, SPARC IBD cohort data
Coding systems: ICD-10-CM, ICD-10-PCS, HCPCS Level I and II, CPT-4, NDC
Sample size (SPARC IBD subset): Vedolizumab n=77; Ustekinumab n=227
Primary measures: Incidence rates per 1000 person-years, hazard ratios with 95% confidence intervals
Citation: Raffals LE, Saha S, Bewtra M, et al. Inflamm Bowel Dis 2022;28:192–199
Supplementary Table 1. Complete Survey Enteral Nutrition for Pediatric IBD – International Questionnaire
Year: 2023
Region / City: Global
Topic: Pediatric IBD, Enteral Nutrition
Document Type: Questionnaire
Institution: ESPGHAN, Canadian Pediatric IBD Network
Author: Eytan
Target Audience: Pediatric gastroenterologists, pediatric gastroenterology nurses, pediatric gastroenterology dietitians
Period of Validity: Ongoing
Approval Date: Not specified
Modification Date: Not specified
Context: International survey aimed at improving enteral nutrition care practices for children with IBD by collecting data from global healthcare professionals on treatment protocols and challenges.
Supplementary figures 2A–2C: ROC curves for amino acid differences in IBD, UC, and CD versus healthy controls
Year: 2026
Field: Biomedical research
Type of document: Supplementary material
Institution: Not specified
Author: Not specified
Target audience: Researchers in gastroenterology and metabolomics
Study groups: IBD, UC, CD, healthy controls
Analytes: Histidine, Leucine, Phenylalanine, Tryptophan, Tyrosine, Valine, Serine
Methodology: Receiver operating characteristic analysis
Comparison: Disease groups versus healthy controls
Data presentation: Graphical figures with ROC curves
Topics: BioResource 210723 IBD